HPLC-based Oligonucleotide Fragment Purification Service

The Purification of Oligonucleotides

As a new generation of gene medicine, oligonucleotides comprise 15-50 nucleotides, which can directly regulate gene expression and thus play a role in treating diseases. Oligonucleotides are usually used as primers for DNA sequencing, and their synthesis speed is fast, but the products are usually mixed with by-products of chemical reactions. Therefore, further purification of products is usually required to remove non-target substances in the chemical reaction, and the purification requires complicated procedures. High-performance liquid chromatography (HPLC) is the earliest chromatographic analysis way for the purification of drugs, containing reversed-phase chromatography (RP-HPLC) and anion-exchange chromatography (IE-HPLC).

HPLC-based Oligonucleotide Fragment Purification Service at CD BioGlyco

CD BioGlyco provides mature HPLC-based oligonucleotide purification services, including purification of unmodified sequences as well as sequences with complex modifications, for example, linkers, spacers, and modified bases. C18 or ion-exchange chromatographic columns are used as tools for HPLC, which are mostly suitable for the purification of sequences with less than 100 bases. HPLC is a column chromatography, and usually, different types can be selected for purification according to the characteristics of the sequence.

RP-HPLC

Separation mechanism

Separation of target sequences from short sequences based on relative hydrophobicity.

  • Retain
    Target sequences contain a dimethoxytrityl (DMT) unit at the 5' OH of the last base. When the hydrophobic 5'-DMT of the desired sequence After the column, hydrophobic interactions can be established with the alkyl chains on the surface of the stationary phase support, which can be highly retained by RP-HPLC.
  • Elute
    Elute the desired sequence by cleaving the 5'-DMT.
  • Tips

    • Due to the capacity and separation performance of RP-HPLC columns, it is often used as the method of choice for large-scale synthesis.
    • As the length of the sequence increases, the hydrophobicity will decrease, while affecting the purity and yield of the product.
    • Standard RP-HPLC can achieve >85% sequence purity.

IE-HPLC

Separation mechanism

Separation of target sequences from short sequences based on relative charge differences.

  • Retain
    After the mixed sequence enters the chromatographic column, it forms a charge interaction with the polycationic stationary phase resin.
  • Elute
    Short sequences are washed away through the ionic strength of the mobile phase increases. The desired sequence is then eluted at a higher ionic strength.
  • Tips

    • Oligonucleotide drugs are highly polar, and the charged group (phosphate) in the backbone has a strong negative charge. Their retention is weak under conventional reversed-phase chromatography conditions, so it is necessary to add ion-pairing reagents to the mobile phase.
    • IE-HPLC purification is possible in the absence of 5'-DMT on the sequence. The method has the characteristics of good separation selectivity, short analysis time, less sample consumption, and less solvent consumption.
    • IE-HPLC is suitable for the purification of small amounts of sequences, usually no more than 40 bases.

HPLC-based oligonucleotide fragment purification.Fig.1 HPLC-based oligonucleotide fragment purification. (CD BioGlyco)

Applications

  • Molecular biology: High-purity oligonucleotide fragments can be obtained for PCR amplification and sequencing reactions.
  • Genetic engineering: Purified and synthesized sequence fragments can be applied to genome editing and protein expression regulation.
  • Drug development: Purified drug candidates help to determine the purity, stability, and activity of drug candidates to support further research and evaluation of drug development.

Advantages

  • CD BioGlyco provides efficient oligonucleotide fragment purification services that quickly separate target compounds and remove by-products.
  • We have established strict quality management system production standards to ensure reliable experimental results.
  • Our purification service has high resolution and will obtain high-purity products (over 85%).

CD BioGlyco offers mature HPLC purification services for your oligonucleotide fragment and delivers high-purity products. When using a single HPLC purification, sequences longer than 70 bases in length or sequences with more than 2 modifications are not guaranteed to be 85% pure. For these sequences, consider a two-step purification to ensure high purity. Other purification techniques used for oligonucleotides are also provided, including Desalination-based Oligonucleotide Fragment Purification, Cartridge (OPC)-based Oligonucleotide Fragment Purification, and PAGE-based Oligonucleotide Fragment Purification. Please feel free to contact us for detailed information if you are interested in oligonucleotide fragment purification services.

References

  1. Gilar, M.; Bouvier, E.S.P. Purification of crude DNA oligonucleotides by solid-phase extraction and reversed-phase high-performance liquid chromatography. J Chromatogr A. 2000, 890(1): 167-177.
  2. Andrus, A.; Kuimelis, R.G. Analysis and purification of synthetic nucleic acids using HPLC. Current protocols in nucleic acid chemistry. 2000, 1(1): 10-15.
  3. GUO, C.F.; et al. Research Progress in Analysis Methods of Oligonucleotide Drugs. Chinese Pharmaceutical Journal. 2022, 57(11): 869-873.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.